Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Watson Acquires Ascent Pharmahealth for AU$375 Million
January 24, 2012
- Watson Becomes 5th Largest Generic Pharmaceutical Company in Australia; Builds on Existing Watson Assets Read More
from PR Newswire
FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length
January 20, 2012
- Preterm birth is a significant and costly problem, affecting one in eight live-born infants in the U.S.; premature cervical shortening is strong risk predictor - Read More
from PR Newswire
Watson Launches Generic Yaz(R)
January 18, 2012
from PR Newswire
Watson to Host Investor Meeting January 24 in New York City
January 12, 2012
from PR Newswire
Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Competition in Generic Drugs Heating Up
January 11, 2012
from Marketwired News Releases
Watson to Present at the 30th Annual J.P. Morgan Healthcare Conference
December 28, 2011
from PR Newswire
Watson to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
December 22, 2011
from PR Newswire
Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars
December 19, 2011
from PR Newswire
Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars
December 19, 2011
from PR Newswire
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
December 08, 2011
-- Novel Formulation Provides Convenience, Efficacy and Excellent Tolerability Read More
from PR Newswire
Watson Launches Generic LoSEASONIQUE(R)
December 07, 2011
from PR Newswire
Critical Alerts for Hewlett-Packard, Newmont Mining, Watson Pharmaceuticals, PulteGroup, and Lincoln National Released by Seven Summits Research
December 01, 2011
from PR Newswire
Watson Launches Generic LIPITOR®
November 30, 2011
- Largest generic product launch in US history - Read More
from PR Newswire
Watson's Generic Yaz(R) Receives FDA Approval
November 29, 2011
from PR Newswire
Watson to Present at the 2011 Piper Jaffray Health Care Conference
November 21, 2011
from PR Newswire
Watson Wins Kentucky Drug Pricing Litigation
November 16, 2011
from PR Newswire
Watson' Launches Generic Kadian(R)
November 10, 2011
from PR Newswire
Watson Confirms Exelon(R) Patent Challenge
November 10, 2011
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson Confirms Appeals Court Decision Rejecting Teva's Motion to Enjoin Watson's Sales of Generic SEASONIQUE®
November 10, 2011
from PR Newswire
Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
November 10, 2011
Advisory Committee for Reproductive Health Drugs Meeting Scheduled for January 20, 2012 Read More
from PR Newswire
Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
November 01, 2011
- 31% Increase in Non-GAAP Net Income - Read More
from PR Newswire
Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
October 28, 2011
from PR Newswire
Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
October 28, 2011
from PR Newswire
FDA Approves Watson's Androderm® (testosterone transdermal system) 2 mg/day and 4 mg/day
October 21, 2011
- New formulation represents 20% reduction in active ingredient; smaller patch size - Read More
from PR Newswire
Watson Confirms Atelvia(TM) Patent Challenge
October 17, 2011
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson Confirms Daytrana(R) Patent Challenge
October 14, 2011
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
October 08, 2011
from PR Newswire
Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
October 07, 2011
from PR Newswire
Watson Confirms EMBEDA(R) Patent Challenge
October 07, 2011
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Global Situation & Resulting Influences - Research Report on BioDelivery Sciences International, Inc. and Watson Pharmaceuticals, Inc.
September 30, 2011
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here